Anika Therapeutics ANIK
NASDAQ ANIK
$19.33 -0.03 (-0.13%)
As of: Oct 2, 2026 · 12:46 PM EDT

Anika Therapeutics (ANIK) Cash from Financing Activities (2010 - 2026)

Updated

Anika Therapeutics (ANIK) reported Cash from Financing Activities of -$701,000 for Q2 2026, compared with $179,000 a year earlier.

Analysis

Anika Therapeutics (ANIK) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Anika Therapeutics' Cash from Financing Activities came in at -$16.34 million; for FY2025, it came in at -$10.55 million.

  • By year, Cash from Financing Activities came in at -$12.73 million in FY2024, -$6.32 million in FY2023, -$4.85 million in FY2022 and -$6.78 million in FY2021.
  • Five-year quarterly Cash from Financing Activities spans a low of -$10.35 million in Q1 2026 and a high of $667,000 in Q4 2022.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$10.35 million (Q1 2026), -$5.28 million (Q4 2025) and -$13,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -1.57 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -3.52 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.27 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -287.90 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -343.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -95.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -410.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -300,000.00
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -577.00 Mn
10 Anika Therapeutics 263.11 Mn -3.44 Mn 21.24 Mn -701,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -701,000.00
Mar 31, 2026 -10.35 Mn
Dec 31, 2025 -5.28 Mn
Sep 30, 2025 -13,000.00
Jun 30, 2025 179,000.00
Mar 31, 2025 -5.44 Mn
Dec 31, 2024 -5.35 Mn
Sep 30, 2024 -3.99 Mn
Jun 30, 2024 -1.11 Mn
Mar 31, 2024 -2.27 Mn
Dec 31, 2023 342,000.00
Sep 30, 2023 -110,000.00
Jun 30, 2023 -4.94 Mn
Mar 31, 2023 -1.61 Mn
Dec 31, 2022 667,000.00
Sep 30, 2022 -4.61 Mn
Jun 30, 2022 -46,000.00
Mar 31, 2022 -862,000.00
Dec 31, 2021 60,000.00
Sep 30, 2021 -6.98 Mn
API Access

Anika Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ANIK&period=max&api_key=YOUR_API_KEY